Precision Biosciences (DTIL) Non-Current Assets (2018 - 2026)

Precision Biosciences (DTIL) has 9 years of Non-Current Assets data on file, last reported at $35.2 million in Q1 2026.

• Non-Current Assets for Q1 2026 came in at $35.2 million, down 16.81% year-over-year; the trailing twelve-month figure through Mar 2026 was $151.3 million (up 2.12% YoY), and the FY2025 annual result was $35.7 million, down 13.82% from the prior year.
• Non-Current Assets fell to $35.2 million in Q1 2026 per DTIL's latest filing, from $35.7 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $49.5 million in Q2 2022 and troughed at $18.5 million in Q3 2023.
• A 5-year average of $36.3 million and a median of $38.7 million in 2025 frame the typical range for Non-Current Assets.
• The sharpest annual moves came in 2023 and 2024: Non-Current Assets slumped 60.12% in 2023, then surged 131.1% in 2024.
• A 5-year view of Non-Current Assets shows it stood at $39.1 million in 2022, then sank by 40.04% to $23.4 million in 2023, then surged by 76.75% to $41.4 million in 2024, then slipped by 13.82% to $35.7 million in 2025, then retreated by 1.34% to $35.2 million in 2026.
• Business Quant data shows DTIL's Non-Current Assets at $35.2 million in Q1 2026, $35.7 million in Q4 2025, and $41.8 million in Q3 2025.